Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1992 | 12-1991 | 12-1990 | 12-1989 | 12-1988 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,264 | 13,186 | 15,489 | 9,515 | 4,686 |
| Marketable Securities | 29,088 | 5,003 | 761 | 672 | 2,965 |
| Receivables | 1,421 | 943 | 1,278 | 1,826 | 1,256 |
| Inventories | 841 | 1,172 | 969 | 914 | 714 |
| Other current assets | 521 | 186 | 268 | 212 | 85 |
| TOTAL | $41,136 | $20,489 | $18,765 | $13,139 | $9,707 |
| Non-Current Assets | |||||
| PPE Net | 6,812 | 4,337 | 4,459 | 4,515 | 4,151 |
| Other Non-Current Assets | 437 | 860 | 872 | 1,165 | 1,470 |
| TOTAL | $7,249 | $5,196 | $5,331 | $5,680 | $5,621 |
| Total Assets | $48,384 | $25,686 | $24,096 | $18,819 | $15,328 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 868 | 561 | 450 | 404 | 236 |
| Accrued Expenses | 375 | 426 | 342 | 291 | 252 |
| TOTAL | $1,243 | $988 | $871 | $989 | $637 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $330 | $341 | $285 |
| Total Liabilities | $1,243 | $988 | $1,201 | $1,330 | $923 |
| Shareholders' Equity | |||||
| Common Shares | 67 | 57 | 33 | 305 | 29 |
| Retained earnings | 2,268 | 2,177 | 5,589 | 5,232 | 4,155 |
| Other shareholders' equity | 0 | 0 | 0 | -275 | 1 |
| TOTAL | $47,141 | $24,698 | $22,895 | $17,489 | $14,406 |
| Total Liabilities And Equity | $48,384 | $25,686 | $24,096 | $18,819 | $15,329 |